Mesothelioma shows promising response to existing immunotherapy drug

Latest Posts

Novartis executive sold shares before drug data manipulation made public

By Lizzy

VIENNA (Reuters) - An unnamed Novartis executive sold 925,400 Swiss francs ($946,000) worth of shares less than three weeks before the U.S. Food and Drug...

Comments closed

Shedding light on how the human eye perceives brightness

By Sheela

Japanese scientists are shedding new light on the importance of light-sensing cells in the retina that process visual information. The researchers isolated the functions of...

Comments closed

Mums-to-be reject baby showers for ‘mother blessings’

By Lizzy

First there was the baby shower, then came the gender-reveal party. Now parents-to-be are embarking on a new way of celebrating imminent parenthood: the “mother...

Comments closed

This App Aims To Save New Moms’ Lives

By Lizzy

Enlarge this image Mahmee CEO Melissa Hanna (right) and her mother Linda Hanna (left) co-founded the company in 2014. Linda's more than 40 years of...

Comments closed

Last-Resort Device OK’d for Advanced Heart Failure

By Lizzy

WASHINGTON -- An implanted cardiac neuromodulator that provides baroreflex stimulation in patients with hard-to-treat advanced heart failure won FDA approval, the agency announced late Friday....

Comments closed

Malignant pleural mesothelioma shows a promising response to treatment with the antibody drug pembrolizumab, which is used to treat other cancers.

Source: MedicalNewsToday.com